Early stage breast cancer conserving treatment: high dose rate brachytherapy boost to the tumour bed
Clin. transl. oncol. (Print)
; 7(8): 344-350, sept. 2005. tab, graf
Article
in En
| IBECS
| ID: ibc-040785
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
ABSTRACT
Introduction. The dose administered to the tumour bed is a risk-factor for local recurrence in localised breast cancer following breast-conserving surgery. Materials and Methods. All patients (n=94) received 50 Gy external beam radiotherapy and one application of 700 cGy at 85% isodose with high dose rate brachytherapy. Results. Of the cases, 84% were infiltrating ductal carcinoma; 31.2% were G3; 28% were intraductal component > 25%; 54% had margin 3 cm (p = 0.001), irradiation volume with external beam radiotherapy (p = 0.0001), and presence of local recurrence (p = 0.001). Conclusion. High dose rate brachytherapy is an effective method for reducing local recurrence, and increasing local control
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Radiotherapy
/
Breast Neoplasms
/
Neoplasm Recurrence, Local
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Clin. transl. oncol. (Print)
Year:
2005
Document type:
Article